{"id":"https://openalex.org/W1978999542","doi":"https://doi.org/10.1159/000318845","title":"Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer\u2019s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study","display_name":"Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer\u2019s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W1978999542","doi":"https://doi.org/10.1159/000318845","mag":"1978999542","pmid":"https://pubmed.ncbi.nlm.nih.gov/20733306","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3214882"},"language":"en","primary_location":{"id":"doi:10.1159/000318845","doi":"https://doi.org/10.1159/000318845","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000318845","pdf_url":null,"source":{"id":"https://openalex.org/S195598543","display_name":"Dementia and Geriatric Cognitive Disorders","issn_l":"1420-8008","issn":["1420-8008","1421-9824"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dementia and Geriatric Cognitive Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3214882","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael Gold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Gold","raw_affiliation_strings":["Neurosciences Medicines Development Center, GlaxoSmithKline, Stockley Park, Harlow, UK. michael.2.gold@gsk.com","Neurosciences Medicines Development Center, GlaxoSmithKline, Stockley Park, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences Medicines Development Center, GlaxoSmithKline, Stockley Park, Harlow, UK. michael.2.gold@gsk.com","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Neurosciences Medicines Development Center, GlaxoSmithKline, Stockley Park, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001091342","display_name":"Claire Alderton","orcid":"https://orcid.org/0000-0002-2975-5744","observed_orcids":["https://orcid.org/0000-0002-2975-5744"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Claire Alderton","raw_affiliation_strings":["GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051730849","display_name":"Marina E. Zvartau-Hind","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marina Zvartau-Hind","raw_affiliation_strings":["GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002223477","display_name":"Sally Egginton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sally Egginton","raw_affiliation_strings":["Neurosciences Medicines Development Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences Medicines Development Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002233555","display_name":"Ann M. Saunders","orcid":"https://orcid.org/0000-0002-8714-8379","observed_orcids":["https://orcid.org/0000-0002-8714-8379"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann M. Saunders","raw_affiliation_strings":["Duke University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109159919","display_name":"Michael C. Irizarry","orcid":"https://orcid.org/0000-0002-0246-2511","observed_orcids":["https://orcid.org/0000-0002-0246-2511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Irizarry","raw_affiliation_strings":["Neurosciences Medicines Development Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences Medicines Development Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019308143","display_name":"Suzanne Craft","orcid":"https://orcid.org/0000-0003-0591-8657","observed_orcids":["https://orcid.org/0000-0003-0591-8657"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne Craft","raw_affiliation_strings":["University of Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073496526","display_name":"Gary E. Landreth","orcid":"https://orcid.org/0000-0002-8808-424X","observed_orcids":["https://orcid.org/0000-0002-8808-424X"]},"institutions":[{"id":"https://openalex.org/I4390039247","display_name":"Case Comprehensive Cancer Center","ror":"https://ror.org/00fpjq451","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039247","https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Landreth","raw_affiliation_strings":["Case Comprehensive Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Comprehensive Cancer Center","institution_ids":["https://openalex.org/I4390039247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061100453","display_name":"\u00dclla Linnam\u00e4gi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56085075","display_name":"University of Tartu","ror":"https://ror.org/03z77qz90","country_code":"EE","type":"education","lineage":["https://openalex.org/I56085075"]}],"countries":["EE"],"is_corresponding":false,"raw_author_name":"\u00dclla Linnam\u00e4gi","raw_affiliation_strings":["University of Tartu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tartu","institution_ids":["https://openalex.org/I56085075"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109249196","display_name":"Sharon T. Sawchak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Sawchak","raw_affiliation_strings":["Neurosciences Medicines Development Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences Medicines Development Center","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":9.3694,"has_fulltext":false,"cited_by_count":365,"citation_normalized_percentile":{"value":0.99014258,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"30","issue":"2","first_page":"131","last_page":"146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.21299999952316284,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9890000224113464},{"id":"https://openalex.org/keywords/peroxisome-proliferator-activated-receptor-gamma-agonists","display_name":"peroxisome proliferator-activated receptor gamma agonists","score":0.8690000176429749},{"id":"https://openalex.org/keywords/apoe-epsilon4-genotype","display_name":"APOE \u03b54 genotype","score":0.7689999938011169},{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.8230000138282776},{"id":"https://openalex.org/keywords/global-function","display_name":"global function","score":0.6759999990463257},{"id":"https://openalex.org/keywords/peripheral-edema","display_name":"peripheral edema","score":0.9520000219345093},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8309999704360962},{"id":"https://openalex.org/keywords/adas-cog","display_name":"ADAS-Cog","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7166187167167664},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6892116069793701},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6336212754249573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5078418850898743},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.49927711486816406},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4722397029399872},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.45823007822036743},{"id":"https://openalex.org/C57089818","wikidata":"https://www.wikidata.org/wiki/Q424728","display_name":"Apolipoprotein E","level":3,"score":0.4367125928401947},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4104151725769043},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4076143205165863},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37749966979026794},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.33082813024520874},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.15046700835227966},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10451361536979675},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077265","descriptor_name":"Donepezil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000483","descriptor_name":"Alleles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D001057","descriptor_name":"Apolipoproteins E","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007361","descriptor_name":"Intelligence Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007406","descriptor_name":"Interview, Psychological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009304","descriptor_name":"Nasopharyngitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1159/000318845","doi":"https://doi.org/10.1159/000318845","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000318845","pdf_url":null,"source":{"id":"https://openalex.org/S195598543","display_name":"Dementia and Geriatric Cognitive Disorders","issn_l":"1420-8008","issn":["1420-8008","1421-9824"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dementia and Geriatric Cognitive Disorders","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3214882","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3214882","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dement Geriatr Cogn Disord","raw_type":"Text"},{"id":"pmid:20733306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20733306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dementia and geriatric cognitive disorders","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3214882","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3214882","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dement Geriatr Cogn Disord","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G4346974243","display_name":"LXR and PPARgamma mediated Abeta clearance mechanisms","funder_award_id":"R01AG030482","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W31749136","https://openalex.org/W57739416","https://openalex.org/W150222691","https://openalex.org/W163864813","https://openalex.org/W1164896577","https://openalex.org/W1820691791","https://openalex.org/W1847168837","https://openalex.org/W1953027527","https://openalex.org/W1976048196","https://openalex.org/W1976571725","https://openalex.org/W1978769917","https://openalex.org/W1989838345","https://openalex.org/W1996671318","https://openalex.org/W1998933601","https://openalex.org/W1999856629","https://openalex.org/W2002937059","https://openalex.org/W2028911700","https://openalex.org/W2029177106","https://openalex.org/W2032605307","https://openalex.org/W2033411034","https://openalex.org/W2038555561","https://openalex.org/W2039140744","https://openalex.org/W2041394188","https://openalex.org/W2047478253","https://openalex.org/W2049837617","https://openalex.org/W2057679568","https://openalex.org/W2060060473","https://openalex.org/W2068456795","https://openalex.org/W2071889472","https://openalex.org/W2072249708","https://openalex.org/W2076041568","https://openalex.org/W2076349824","https://openalex.org/W2076676029","https://openalex.org/W2077151295","https://openalex.org/W2081285591","https://openalex.org/W2081434082","https://openalex.org/W2083337622","https://openalex.org/W2085646105","https://openalex.org/W2097077265","https://openalex.org/W2097335530","https://openalex.org/W2099271519","https://openalex.org/W2102343148","https://openalex.org/W2107327698","https://openalex.org/W2111963393","https://openalex.org/W2112150247","https://openalex.org/W2121476689","https://openalex.org/W2122692162","https://openalex.org/W2127993357","https://openalex.org/W2140402757","https://openalex.org/W2156144412","https://openalex.org/W2156220037","https://openalex.org/W2166853536","https://openalex.org/W2167075666","https://openalex.org/W2410611139","https://openalex.org/W2425717984","https://openalex.org/W2473786944"],"related_works":["https://openalex.org/W2005001179","https://openalex.org/W1963826677","https://openalex.org/W2584295583","https://openalex.org/W2747094732","https://openalex.org/W2099271519","https://openalex.org/W2146876810","https://openalex.org/W1982381414","https://openalex.org/W2746658563","https://openalex.org/W2379636260","https://openalex.org/W2004537016"],"abstract_inverted_index":{"BACKGROUND/AIMS:":[0],"A":[1],"phase":[2,33],"II":[3],"study":[4,35,59,76],"of":[5,50,66,131,216,218,245],"the":[6,46,61,117,157,186,191,235],"peroxisome":[7],"proliferator-activated":[8],"receptor-\u03b3":[9],"agonist":[10],"rosiglitazone":[11],"extended":[12],"release":[13],"(RSG":[14],"XR)":[15],"in":[16,27,53,116,146,150,161,174,227,234],"mild-to-moderate":[17,54],"Alzheimer's":[18,118],"disease":[19],"(AD)":[20],"detected":[21,154,173,181,233],"a":[22,177],"treatment":[23,170],"benefit":[24],"to":[25,44,91,113],"cognition":[26,228],"apolipoprotein":[28],"E(APOE)-\u03b54-negative":[29],"subjects.":[30,79],"The":[31,241],"current":[32],"III":[34],"with":[36,155,250],"prospective":[37],"stratification":[38],"by":[39],"APOE":[40,82],"genotype":[41],"was":[42,172,180,190,232,248],"conducted":[43],"confirm":[45],"efficacy":[47,217],"and":[48,64,125,202,205,243],"safety":[49,63,242],"RSG":[51,69,96,100,158,199,210,224,246],"XR":[52,101,159,200,211,225,247],"AD.":[55],"An":[56],"open-label":[57],"extension":[58],"assessed":[60],"long-term":[62],"tolerability":[65,244],"8":[67,98,197,222],"mg":[68,95,99,104,198,209,220,223],"XR.":[70],"METHODS:":[71],"This":[72],"double-blind,":[73],"randomized,":[74],"placebo-controlled":[75],"enrolled":[77],"693":[78],"Within":[80],"2":[81,94,208,219],"allelic":[83],"strata":[84],"(\u03b54-positive,":[85],"\u03b54-negative),":[86],"subjects":[87,163],"were":[88,109,153],"randomized":[89],"(2:2:2:1)":[90],"once-daily":[92],"placebo,":[93],"XR,":[97],"or":[102,164,221,229,237],"10":[103],"donepezil":[105],"(control).":[106],"Coprimary":[107],"endpoints":[108,152],"change":[110,147],"from":[111,144,148],"baseline":[112,149],"week":[114,126,139],"24":[115,127],"Disease":[119],"Assessment":[120],"Scale-cognitive":[121],"subscale":[122],"(ADAS-Cog)":[123],"score,":[124],"Clinician's":[128],"Interview-Based":[129],"Impression":[130],"Change":[132],"plus":[133],"caregiver":[134],"input":[135],"(CIBIC+).":[136],"RESULTS:":[137],"At":[138],"24,":[140],"no":[141,168],"significant":[142,169,178],"differences":[143],"placebo":[145,203],"coprimary":[151],"either":[156],"dose":[160],"APOE-\u03b54-negative":[162,236],"overall.":[165],"For":[166],"donepezil,":[167],"difference":[171,179],"ADAS-Cog;":[175],"however,":[176],"(p":[182],"=":[183],"0.009)":[184],"on":[185],"CIBIC+.":[187],"Peripheral":[188],"edema":[189],"most":[192],"common":[193],"adverse":[194],"event":[195],"for":[196,207],"(15%)":[201],"(5%),":[204],"nasopharyngitis":[206],"(7%).":[212],"CONCLUSION:":[213],"No":[214],"evidence":[215],"monotherapy":[226],"global":[230],"function":[231],"other":[238],"analysis":[239],"populations.":[240],"consistent":[249],"its":[251],"known":[252],"pharmacology.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":21},{"year":2022,"cited_by_count":24},{"year":2021,"cited_by_count":25},{"year":2020,"cited_by_count":27},{"year":2019,"cited_by_count":23},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":25},{"year":2013,"cited_by_count":25},{"year":2012,"cited_by_count":31}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}